Your Article Summary
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma
Endocrine-Related Cancer, 06/04/09
Durante C et al. - In a study to evaluate the long-term outcome and prognostic factors for survival in pts with distant metastases from gastroenteropancreatic well-differentiated endocrine carcinoma (GEP WDEC), this study enables the stratification of metastatic GEP WDEC pts into distinct risk groups. These risk categories can be used to tailor therapeutic approaches and to design and interpret clinical trials.
Methods- Long-term outcome and prognostic factors for survival were evaluated in 118 pts with distant metastases from GEP WDEC.
- Inclusion criteria included pathological review by a single pathologist according to WHO criteria, absence of previous therapy apart from surgery, complete morphological evaluation within 3 mos including somatostatin receptor scintigraphy, and follow-up at Gustave-Roussy Institute until death or study's end.
- Clinical, biological marker, and pathological parameters were analyzed in univariate and multivariate statistical models.
- Survival after the first complete imaging work-up of the metastatic disease was determined using Kaplan–Meier method.
- Survival for 5 yrs after diagnosis of metastatic disease was 54%.
- In multivariate analysis, age, number of liver metastases, tumor slope, and initial surgery were predictive of survival.
- 5-yr survival was 100%, 91%, 62%, and 9% when pts had 0, 1, 2, 3, or more poor prognostic features, respectively.
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Carbohydrate-restricted diets for obesity and related diseases: An update
Current Atherosclerosis Reports, 11/17/09
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09
Comparison of Simvastatin and Metformin in Treatment of Polycystic Ovary Syndrome: Prospective Randomized Trial
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Approach to Thrombocytopenia in Older Adults
Geriatrics & Aging, 11/10/09
Update on oral lichen planus
Expert Review of Dermatology, 10/14/09
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09

See Latest Articles